EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hopamine as Personalized Medicine for Persons with Parkinson’s Disease

Marina A Noordegraaf, Sanne W van den Berg, Bastiaan R Bloem

Journal of Parkinson’s Disease · 2023

DOI: 10.3233/jpd-230012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, 2023. Verfasst von Marina A Noordegraaf und 2 weiteren Autor:innen. Beteiligte Einrichtung: Patient Advocate and Patient Researcher at the Dutch Parkinson's Association, The Netherlands. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prescribing dopamine replacement therapy remains the most common approach used by physicians who strive to support persons with Parkinson’s disease. In this viewpoint, we argue that instead of merely prescribing dopamine, healthcare professionals should particularly encourage and enable persons with Parkinson’s disease to draft their own personalized prescription of “ hopamine”. The term hopamine is a self-invented neologism representing the uniquely personal set of hopes, desires, experiences, and skills of each individual with a dopamine deficit. As such, the concept of hopamine–as a reflection of the unique personal characteristics of each person with Parkinson’s disease—really supplements that of dopamine–as a reflection of each person’s unique physical characteristics. Whereas a prescription of dopamine replacement medication necessitates the diagnosed individual to lay his or her fate in the hands of medical professionals, adding a personalized dose of hopamine to the therapeutic mix empowers persons to self-manage daily life with Parkinson’s disease. In this viewpoint, we argue that hopamine is a prerequisite for personalized medicine and offer several practical recommendations for how medical professionals can introduce the concept of hopamine in daily clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHumansMaleFemaleDopaminePrecision MedicineDopamine AgentsCognition

Stichwörter der Autor:innen

DopamineParkinson’s diseasehopaminehopepersonalized care managementpersonalized medicine

Substanzen

DopamineDopamine Agents

Autor:innen und Institutionen

  • Patient Advocate and Patient Researcher at the Dutch Parkinson's Association, The Netherlands.
  • Radboud University Medical Centre; Donders Institute for Brain, Cognition and Behaviour; Department of Neurology; Centre of Expertise for Parkinson & Movement Disorders, Nijmegen, The Netherlands.

Zitieren

APA

Noordegraaf, M. A., van den Berg, S. W., & Bloem, B. R. (2023). Hopamine as Personalized Medicine for Persons with Parkinson’s Disease. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-230012

Vancouver

Noordegraaf MA, van den Berg SW, Bloem BR. Hopamine as Personalized Medicine for Persons with Parkinson’s Disease. Journal of Parkinson’s Disease. 2023. doi:10.3233/jpd-230012

BibTeX
@article{Noordegraaf2023,
  author = {Noordegraaf, Marina A and van den Berg, Sanne W and Bloem, Bastiaan R},
  title = {Hopamine as Personalized Medicine for Persons with Parkinson’s Disease},
  journal = {Journal of Parkinson’s Disease},
  year = {2023},
  doi = {10.3233/jpd-230012}
}
Kostenlos starten →